Global Long-acting GLP-1 Therapy Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Long-acting GLP-1 Therapy competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Long-acting GLP-1 therapy means GLP-1–receptor–based medicines engineered to last a week (or longer) so they’re dosed once weekly rather than daily/twice-daily. They give steadier receptor activation for type 2 diabetes control and chronic weight management by boosting glucose-dependent insulin, slowing gastric emptying, and suppressing appetite. In 2024, global Long-acting GLP-1 Therapy production reached approximately 45234 K Unit, with an average global market price of around US$ 511 per unit.Market outlook: GLP-1 therapies are set for sustained hypergrowth over the next 5–10 years as obesity care globalizes beyond type 2 diabetes, supported by compelling outcomes data, expanding payor coverage, and strong consumer pull for chronic weight management.Industry chain (upstream?midstream): Upstream consists of peptide APIs (solid-phase synthesis, high-capacity preparative chromatography, PEGylation/lipidation linkers), device components (autoinjectors, pens, safety needles), and excipients, while midstream innovators integrate long-acting analog design, fill-finish, device pairing, and global regulatory/CMC to deliver branded combination drug–device products.Downstream & ecosystem: Downstream demand flows through endocrinology and primary-care channels, obesity clinics, digital telehealth platforms, and employer/payer programs, with adherence, supply continuity, and step-therapy rules shaping real-world volumes and with compounding and biosimilar entry emerging as price/modality pressure over time.Growth drivers & constraints: Growth is propelled by superior cardiometabolic outcomes (A1c, weight loss, CV risk signals), label and geography expansion, and pipeline next-gen incretin combos (GLP-1/GIP/GCGR), while constraints include manufacturing scale for complex peptides, device capacity, reimbursement variability, GI tolerability/attrition, and eventual price erosion from competition and biosimilars.Economics (gross margins): At scale, branded GLP-1 drug–device products typically achieve ~75–90% gross margins for originators (high list prices, efficient peptide and device supply), ~20–35% for contract manufacturers/device suppliers, and ~10–20% for distribution/dispensing, with blended margins compressing over time as pricing pressure, rebates, and competitive entrants increase.
The global Long-acting GLP-1 Therapy market size was estimated at USD 23115.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Long-acting GLP-1 Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Long-acting GLP-1 Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Long-acting GLP-1 Therapy market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting GLP-1 Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting GLP-1 Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Long-acting GLP-1 Therapy market size was estimated at USD 23115.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 19.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Long-acting GLP-1 Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Long-acting GLP-1 Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Long-acting GLP-1 Therapy market.
Global Long-acting GLP-1 Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Novo Nordisk
- Eli Lilly
- AstraZeneca (legacy)
Market Segmentation (by Type)
- Injection
- Oral
Market Segmentation (by Application)
- Type 2 Diabetes
- Obesity/Weight Management
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Long-acting GLP-1 Therapy Market
Overview of the regional outlook of the Long-acting GLP-1 Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting GLP-1 Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting GLP-1 Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Long-acting GLP-1 Therapy
1.2 Key Market Segments
1.2.1 Long-acting GLP-1 Therapy Segment by Type
1.2.2 Long-acting GLP-1 Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING GLP-1 THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting GLP-1 Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Long-acting GLP-1 Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING GLP-1 THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Long-acting GLP-1 Therapy Product Life Cycle
3.3 Global Long-acting GLP-1 Therapy Sales by Manufacturers (2020-2025)
3.4 Global Long-acting GLP-1 Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Long-acting GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Long-acting GLP-1 Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Long-acting GLP-1 Therapy Market Competitive Situation and Trends
3.8.1 Long-acting GLP-1 Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Long-acting GLP-1 Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING GLP-1 THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Long-acting GLP-1 Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING GLP-1 THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Long-acting GLP-1 Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Long-acting GLP-1 Therapy Market
5.7 ESG Ratings of Leading Companies
6 LONG-ACTING GLP-1 THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting GLP-1 Therapy Sales Market Share by Type (2020-2025)
6.3 Global Long-acting GLP-1 Therapy Market Size by Type (2020-2025)
6.4 Global Long-acting GLP-1 Therapy Price by Type (2020-2025)
7 LONG-ACTING GLP-1 THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting GLP-1 Therapy Market Sales by Application (2020-2025)
7.3 Global Long-acting GLP-1 Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Long-acting GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
8 LONG-ACTING GLP-1 THERAPY MARKET SALES BY REGION
8.1 Global Long-acting GLP-1 Therapy Sales by Region
8.1.1 Global Long-acting GLP-1 Therapy Sales by Region
8.1.2 Global Long-acting GLP-1 Therapy Sales Market Share by Region
8.2 Global Long-acting GLP-1 Therapy Market Size by Region
8.2.1 Global Long-acting GLP-1 Therapy Market Size by Region
8.2.2 Global Long-acting GLP-1 Therapy Market Size by Region
8.3 North America
8.3.1 North America Long-acting GLP-1 Therapy Sales by Country
8.3.2 North America Long-acting GLP-1 Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Long-acting GLP-1 Therapy Sales by Country
8.4.2 Europe Long-acting GLP-1 Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Long-acting GLP-1 Therapy Sales by Region
8.5.2 Asia Pacific Long-acting GLP-1 Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Long-acting GLP-1 Therapy Sales by Country
8.6.2 South America Long-acting GLP-1 Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Long-acting GLP-1 Therapy Sales by Region
8.7.2 Middle East and Africa Long-acting GLP-1 Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LONG-ACTING GLP-1 THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting GLP-1 Therapy by Region(2020-2025)
9.2 Global Long-acting GLP-1 Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Long-acting GLP-1 Therapy Production
9.4.1 North America Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.4.2 North America Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Long-acting GLP-1 Therapy Production
9.5.1 Europe Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Long-acting GLP-1 Therapy Production (2020-2025)
9.6.1 Japan Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Long-acting GLP-1 Therapy Production (2020-2025)
9.7.1 China Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.7.2 China Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk Long-acting GLP-1 Therapy Product Overview
10.1.3 Novo Nordisk Long-acting GLP-1 Therapy Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Basic Information
10.2.2 Eli Lilly Long-acting GLP-1 Therapy Product Overview
10.2.3 Eli Lilly Long-acting GLP-1 Therapy Product Market Performance
10.2.4 Eli Lilly Business Overview
10.2.5 Eli Lilly SWOT Analysis
10.2.6 Eli Lilly Recent Developments
10.3 AstraZeneca (legacy)
10.3.1 AstraZeneca (legacy) Basic Information
10.3.2 AstraZeneca (legacy) Long-acting GLP-1 Therapy Product Overview
10.3.3 AstraZeneca (legacy) Long-acting GLP-1 Therapy Product Market Performance
10.3.4 AstraZeneca (legacy) Business Overview
10.3.5 AstraZeneca (legacy) SWOT Analysis
10.3.6 AstraZeneca (legacy) Recent Developments
11 LONG-ACTING GLP-1 THERAPY MARKET FORECAST BY REGION
11.1 Global Long-acting GLP-1 Therapy Market Size Forecast
11.2 Global Long-acting GLP-1 Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting GLP-1 Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting GLP-1 Therapy Market Size Forecast by Region
11.2.4 South America Long-acting GLP-1 Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Long-acting GLP-1 Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Long-acting GLP-1 Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Long-acting GLP-1 Therapy by Type (2026-2035)
12.1.2 Global Long-acting GLP-1 Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Long-acting GLP-1 Therapy by Type (2026-2035)
12.2 Global Long-acting GLP-1 Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Long-acting GLP-1 Therapy Sales (K MT) Forecast by Application
12.2.2 Global Long-acting GLP-1 Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Long-acting GLP-1 Therapy
1.2 Key Market Segments
1.2.1 Long-acting GLP-1 Therapy Segment by Type
1.2.2 Long-acting GLP-1 Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING GLP-1 THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting GLP-1 Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Long-acting GLP-1 Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING GLP-1 THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Long-acting GLP-1 Therapy Product Life Cycle
3.3 Global Long-acting GLP-1 Therapy Sales by Manufacturers (2020-2025)
3.4 Global Long-acting GLP-1 Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Long-acting GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Long-acting GLP-1 Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Long-acting GLP-1 Therapy Market Competitive Situation and Trends
3.8.1 Long-acting GLP-1 Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Long-acting GLP-1 Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING GLP-1 THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Long-acting GLP-1 Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING GLP-1 THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Long-acting GLP-1 Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Long-acting GLP-1 Therapy Market
5.7 ESG Ratings of Leading Companies
6 LONG-ACTING GLP-1 THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting GLP-1 Therapy Sales Market Share by Type (2020-2025)
6.3 Global Long-acting GLP-1 Therapy Market Size by Type (2020-2025)
6.4 Global Long-acting GLP-1 Therapy Price by Type (2020-2025)
7 LONG-ACTING GLP-1 THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting GLP-1 Therapy Market Sales by Application (2020-2025)
7.3 Global Long-acting GLP-1 Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Long-acting GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
8 LONG-ACTING GLP-1 THERAPY MARKET SALES BY REGION
8.1 Global Long-acting GLP-1 Therapy Sales by Region
8.1.1 Global Long-acting GLP-1 Therapy Sales by Region
8.1.2 Global Long-acting GLP-1 Therapy Sales Market Share by Region
8.2 Global Long-acting GLP-1 Therapy Market Size by Region
8.2.1 Global Long-acting GLP-1 Therapy Market Size by Region
8.2.2 Global Long-acting GLP-1 Therapy Market Size by Region
8.3 North America
8.3.1 North America Long-acting GLP-1 Therapy Sales by Country
8.3.2 North America Long-acting GLP-1 Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Long-acting GLP-1 Therapy Sales by Country
8.4.2 Europe Long-acting GLP-1 Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Long-acting GLP-1 Therapy Sales by Region
8.5.2 Asia Pacific Long-acting GLP-1 Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Long-acting GLP-1 Therapy Sales by Country
8.6.2 South America Long-acting GLP-1 Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Long-acting GLP-1 Therapy Sales by Region
8.7.2 Middle East and Africa Long-acting GLP-1 Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LONG-ACTING GLP-1 THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting GLP-1 Therapy by Region(2020-2025)
9.2 Global Long-acting GLP-1 Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Long-acting GLP-1 Therapy Production
9.4.1 North America Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.4.2 North America Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Long-acting GLP-1 Therapy Production
9.5.1 Europe Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Long-acting GLP-1 Therapy Production (2020-2025)
9.6.1 Japan Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Long-acting GLP-1 Therapy Production (2020-2025)
9.7.1 China Long-acting GLP-1 Therapy Production Growth Rate (2020-2025)
9.7.2 China Long-acting GLP-1 Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk Long-acting GLP-1 Therapy Product Overview
10.1.3 Novo Nordisk Long-acting GLP-1 Therapy Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Basic Information
10.2.2 Eli Lilly Long-acting GLP-1 Therapy Product Overview
10.2.3 Eli Lilly Long-acting GLP-1 Therapy Product Market Performance
10.2.4 Eli Lilly Business Overview
10.2.5 Eli Lilly SWOT Analysis
10.2.6 Eli Lilly Recent Developments
10.3 AstraZeneca (legacy)
10.3.1 AstraZeneca (legacy) Basic Information
10.3.2 AstraZeneca (legacy) Long-acting GLP-1 Therapy Product Overview
10.3.3 AstraZeneca (legacy) Long-acting GLP-1 Therapy Product Market Performance
10.3.4 AstraZeneca (legacy) Business Overview
10.3.5 AstraZeneca (legacy) SWOT Analysis
10.3.6 AstraZeneca (legacy) Recent Developments
11 LONG-ACTING GLP-1 THERAPY MARKET FORECAST BY REGION
11.1 Global Long-acting GLP-1 Therapy Market Size Forecast
11.2 Global Long-acting GLP-1 Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting GLP-1 Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting GLP-1 Therapy Market Size Forecast by Region
11.2.4 South America Long-acting GLP-1 Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Long-acting GLP-1 Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Long-acting GLP-1 Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Long-acting GLP-1 Therapy by Type (2026-2035)
12.1.2 Global Long-acting GLP-1 Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Long-acting GLP-1 Therapy by Type (2026-2035)
12.2 Global Long-acting GLP-1 Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Long-acting GLP-1 Therapy Sales (K MT) Forecast by Application
12.2.2 Global Long-acting GLP-1 Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Long-acting GLP-1 Therapy Market Size by Type (M USD)
Table 4. Global Long-acting GLP-1 Therapy Market Size by Application
Table 5. Long-acting GLP-1 Therapy Market Size Comparison by Region (M USD)
Table 6. Global Long-acting GLP-1 Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Long-acting GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Long-acting GLP-1 Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Long-acting GLP-1 Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting GLP-1 Therapy as of 2025)
Table 11. Global Market Long-acting GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Long-acting GLP-1 Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting GLP-1 Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Long-acting GLP-1 Therapy Sales by Type (K MT)
Table 27. Global Long-acting GLP-1 Therapy Market Size by Type (M USD)
Table 28. Global Long-acting GLP-1 Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Long-acting GLP-1 Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Long-acting GLP-1 Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Long-acting GLP-1 Therapy Market Share by Type (2020-2025)
Table 32. Global Long-acting GLP-1 Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Long-acting GLP-1 Therapy Sales (K MT) by Application
Table 34. Global Long-acting GLP-1 Therapy Market Size by Application
Table 35. Global Long-acting GLP-1 Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Long-acting GLP-1 Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Long-acting GLP-1 Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Long-acting GLP-1 Therapy Market Share by Application (2020-2025)
Table 39. Global Long-acting GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Long-acting GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Long-acting GLP-1 Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Long-acting GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Long-acting GLP-1 Therapy Market Size by Region (2020-2025)
Table 44. North America Long-acting GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Long-acting GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Long-acting GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Long-acting GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Long-acting GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Long-acting GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Long-acting GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Long-acting GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Long-acting GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Long-acting GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Long-acting GLP-1 Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Long-acting GLP-1 Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Long-acting GLP-1 Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk Long-acting GLP-1 Therapy Product Overview
Table 64. Novo Nordisk Long-acting GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Eli Lilly Basic Information
Table 69. Eli Lilly Long-acting GLP-1 Therapy Product Overview
Table 70. Eli Lilly Long-acting GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly SWOT Analysis
Table 73. Eli Lilly Recent Developments
Table 74. AstraZeneca (legacy) Basic Information
Table 75. AstraZeneca (legacy) Long-acting GLP-1 Therapy Product Overview
Table 76. AstraZeneca (legacy) Long-acting GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AstraZeneca (legacy) Business Overview
Table 78. AstraZeneca (legacy) SWOT Analysis
Table 79. AstraZeneca (legacy) Recent Developments
Table 80. Global Long-acting GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 81. Global Long-acting GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 82. North America Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 83. North America Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 84. Europe Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 85. Europe Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 86. Asia Pacific Long-acting GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 87. Asia Pacific Long-acting GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 88. South America Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 89. South America Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 90. Middle East and Africa Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 91. Middle East and Africa Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Global Long-acting GLP-1 Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 93. Global Long-acting GLP-1 Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 94. Global Long-acting GLP-1 Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 95. Global Long-acting GLP-1 Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 96. Global Long-acting GLP-1 Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Long-acting GLP-1 Therapy Market Size by Type (M USD)
Table 4. Global Long-acting GLP-1 Therapy Market Size by Application
Table 5. Long-acting GLP-1 Therapy Market Size Comparison by Region (M USD)
Table 6. Global Long-acting GLP-1 Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Long-acting GLP-1 Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Long-acting GLP-1 Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Long-acting GLP-1 Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting GLP-1 Therapy as of 2025)
Table 11. Global Market Long-acting GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Long-acting GLP-1 Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting GLP-1 Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Long-acting GLP-1 Therapy Sales by Type (K MT)
Table 27. Global Long-acting GLP-1 Therapy Market Size by Type (M USD)
Table 28. Global Long-acting GLP-1 Therapy Sales (K MT) by Type (2020-2025)
Table 29. Global Long-acting GLP-1 Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Long-acting GLP-1 Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Long-acting GLP-1 Therapy Market Share by Type (2020-2025)
Table 32. Global Long-acting GLP-1 Therapy Price (USD/KG) by Type (2020-2025)
Table 33. Global Long-acting GLP-1 Therapy Sales (K MT) by Application
Table 34. Global Long-acting GLP-1 Therapy Market Size by Application
Table 35. Global Long-acting GLP-1 Therapy Sales by Application (2020-2025) & (K MT)
Table 36. Global Long-acting GLP-1 Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Long-acting GLP-1 Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Long-acting GLP-1 Therapy Market Share by Application (2020-2025)
Table 39. Global Long-acting GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Long-acting GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 41. Global Long-acting GLP-1 Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Long-acting GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Long-acting GLP-1 Therapy Market Size by Region (2020-2025)
Table 44. North America Long-acting GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 45. North America Long-acting GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Long-acting GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 47. Europe Long-acting GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Long-acting GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Long-acting GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Long-acting GLP-1 Therapy Sales by Country (2020-2025) & (K MT)
Table 51. South America Long-acting GLP-1 Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Long-acting GLP-1 Therapy Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Long-acting GLP-1 Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Long-acting GLP-1 Therapy Production (K MT) by Region(2020-2025)
Table 55. Global Long-acting GLP-1 Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Long-acting GLP-1 Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Long-acting GLP-1 Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk Long-acting GLP-1 Therapy Product Overview
Table 64. Novo Nordisk Long-acting GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Eli Lilly Basic Information
Table 69. Eli Lilly Long-acting GLP-1 Therapy Product Overview
Table 70. Eli Lilly Long-acting GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly SWOT Analysis
Table 73. Eli Lilly Recent Developments
Table 74. AstraZeneca (legacy) Basic Information
Table 75. AstraZeneca (legacy) Long-acting GLP-1 Therapy Product Overview
Table 76. AstraZeneca (legacy) Long-acting GLP-1 Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AstraZeneca (legacy) Business Overview
Table 78. AstraZeneca (legacy) SWOT Analysis
Table 79. AstraZeneca (legacy) Recent Developments
Table 80. Global Long-acting GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 81. Global Long-acting GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 82. North America Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 83. North America Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 84. Europe Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 85. Europe Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 86. Asia Pacific Long-acting GLP-1 Therapy Sales Forecast by Region (2026-2035) & (K MT)
Table 87. Asia Pacific Long-acting GLP-1 Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 88. South America Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (K MT)
Table 89. South America Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 90. Middle East and Africa Long-acting GLP-1 Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 91. Middle East and Africa Long-acting GLP-1 Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Global Long-acting GLP-1 Therapy Sales Forecast by Type (2026-2035) & (K MT)
Table 93. Global Long-acting GLP-1 Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 94. Global Long-acting GLP-1 Therapy Price Forecast by Type (2026-2035) & (USD/KG)
Table 95. Global Long-acting GLP-1 Therapy Sales (K MT) Forecast by Application (2026-2035)
Table 96. Global Long-acting GLP-1 Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Long-acting GLP-1 Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting GLP-1 Therapy Market Size (M USD), 2025-2035
Figure 5. Global Long-acting GLP-1 Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Long-acting GLP-1 Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting GLP-1 Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Long-acting GLP-1 Therapy Product Life Cycle
Figure 13. Long-acting GLP-1 Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Long-acting GLP-1 Therapy Revenue Share by Manufacturers in 2025
Figure 15. Long-acting GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Long-acting GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Long-acting GLP-1 Therapy Revenue in 2025
Figure 18. Industry Chain Map of Long-acting GLP-1 Therapy
Figure 19. Global Long-acting GLP-1 Therapy Market PEST Analysis
Figure 20. Global Long-acting GLP-1 Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Long-acting GLP-1 Therapy Market Share by Type
Figure 27. Sales Market Share of Long-acting GLP-1 Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Long-acting GLP-1 Therapy by Type in 2025
Figure 29. Market Share of Long-acting GLP-1 Therapy by Type (2020-2025)
Figure 30. Market Share of Long-acting GLP-1 Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Long-acting GLP-1 Therapy Market Share by Application
Figure 33. Global Long-acting GLP-1 Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Long-acting GLP-1 Therapy Sales Market Share by Application in 2025
Figure 35. Global Long-acting GLP-1 Therapy Market Share by Application (2020-2025)
Figure 36. Global Long-acting GLP-1 Therapy Market Share by Application in 2025
Figure 37. Global Long-acting GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Long-acting GLP-1 Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Long-acting GLP-1 Therapy Market Size by Region (2020-2025)
Figure 40. North America Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Long-acting GLP-1 Therapy Sales Market Share by Country in 2024
Figure 43. North America Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Long-acting GLP-1 Therapy Market Size by Country in 2024
Figure 45. U.S. Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Long-acting GLP-1 Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Long-acting GLP-1 Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Long-acting GLP-1 Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Long-acting GLP-1 Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Long-acting GLP-1 Therapy Sales Market Share by Country in 2024
Figure 53. Europe Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Long-acting GLP-1 Therapy Market Size by Country in 2024
Figure 55. Germany Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Long-acting GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Long-acting GLP-1 Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Long-acting GLP-1 Therapy Market Size by Region in 2024
Figure 68. China Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Long-acting GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 79. South America Long-acting GLP-1 Therapy Sales Market Share by Country in 2024
Figure 80. South America Long-acting GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Long-acting GLP-1 Therapy Market Size by Country in 2024
Figure 82. Brazil Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Long-acting GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Long-acting GLP-1 Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Long-acting GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Long-acting GLP-1 Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Long-acting GLP-1 Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Long-acting GLP-1 Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Long-acting GLP-1 Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Long-acting GLP-1 Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Long-acting GLP-1 Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Long-acting GLP-1 Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Long-acting GLP-1 Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Long-acting GLP-1 Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting GLP-1 Therapy Market Size (M USD), 2025-2035
Figure 5. Global Long-acting GLP-1 Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Long-acting GLP-1 Therapy Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting GLP-1 Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Long-acting GLP-1 Therapy Product Life Cycle
Figure 13. Long-acting GLP-1 Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Long-acting GLP-1 Therapy Revenue Share by Manufacturers in 2025
Figure 15. Long-acting GLP-1 Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Long-acting GLP-1 Therapy Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Long-acting GLP-1 Therapy Revenue in 2025
Figure 18. Industry Chain Map of Long-acting GLP-1 Therapy
Figure 19. Global Long-acting GLP-1 Therapy Market PEST Analysis
Figure 20. Global Long-acting GLP-1 Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Long-acting GLP-1 Therapy Market Share by Type
Figure 27. Sales Market Share of Long-acting GLP-1 Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Long-acting GLP-1 Therapy by Type in 2025
Figure 29. Market Share of Long-acting GLP-1 Therapy by Type (2020-2025)
Figure 30. Market Share of Long-acting GLP-1 Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Long-acting GLP-1 Therapy Market Share by Application
Figure 33. Global Long-acting GLP-1 Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Long-acting GLP-1 Therapy Sales Market Share by Application in 2025
Figure 35. Global Long-acting GLP-1 Therapy Market Share by Application (2020-2025)
Figure 36. Global Long-acting GLP-1 Therapy Market Share by Application in 2025
Figure 37. Global Long-acting GLP-1 Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Long-acting GLP-1 Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Long-acting GLP-1 Therapy Market Size by Region (2020-2025)
Figure 40. North America Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Long-acting GLP-1 Therapy Sales Market Share by Country in 2024
Figure 43. North America Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Long-acting GLP-1 Therapy Market Size by Country in 2024
Figure 45. U.S. Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Long-acting GLP-1 Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Long-acting GLP-1 Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Long-acting GLP-1 Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Long-acting GLP-1 Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Long-acting GLP-1 Therapy Sales Market Share by Country in 2024
Figure 53. Europe Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Long-acting GLP-1 Therapy Market Size by Country in 2024
Figure 55. Germany Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Long-acting GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Long-acting GLP-1 Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Long-acting GLP-1 Therapy Market Size by Region in 2024
Figure 68. China Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Long-acting GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 79. South America Long-acting GLP-1 Therapy Sales Market Share by Country in 2024
Figure 80. South America Long-acting GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Long-acting GLP-1 Therapy Market Size by Country in 2024
Figure 82. Brazil Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Long-acting GLP-1 Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Long-acting GLP-1 Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Long-acting GLP-1 Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Long-acting GLP-1 Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Long-acting GLP-1 Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Long-acting GLP-1 Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Long-acting GLP-1 Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Long-acting GLP-1 Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Long-acting GLP-1 Therapy Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Long-acting GLP-1 Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Long-acting GLP-1 Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Long-acting GLP-1 Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Long-acting GLP-1 Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Long-acting GLP-1 Therapy Market Share Forecast by Application (2026-2035)
